Tobin James R exercised Options covering 30,000 Globus Medical shares and sold 30,000 shares at $74.58 per share on 2026-09-15. The transactions left him with 0 shares and 0 derivative securities, representing 100.0% of his prior holdings in each category and eliminating his reported position.
Key Highlights
- The option exercises involved prices ranging from $53.75 to $63.68 per share.
- Tobin James R owned 30,000 Globus Medical shares after the exercises.
- The derivative-security transactions occurred at $0 per share and left 0 derivative securities.
Tobin James R changed his Globus Medical (NYSE: GMED) position on 15 September 2026 through option exercises covering 30,000 shares. He then sold 30,000 shares at $74.58 per share.
Option Exercises Covered Two Transactions
The transactions occurred across two separate entries, with exercise prices ranging from $53.75 to $63.68 per share. A separate set of option exercises covered 30,000 derivative securities across two transactions. Those derivative securities were recorded at $0 per share. After the exercises, Tobin James R held 30,000 Globus Medical shares, equal to about 100.0% of his resulting share holding. Following that transaction, he owned 0 shares, representing about 100.0% of his prior shares holding. The derivative-security transactions also left him with 0 derivative securities, representing about 100.0% of his prior derivative securities holding.
FAQs
Q: What did Tobin James R do with Globus Medical options?
A: Tobin James R exercised options covering Globus Medical shares and derivative securities. He later sold the resulting shares in a separate transaction.
Q: How many Globus Medical shares did Tobin James R hold after the sale?
A: Tobin James R held 0 Globus Medical shares after the sale. The transaction represented about 100.0% of his prior shares holding.
Q: What prices applied to the Globus Medical option exercises?
A: The share-related exercises occurred at prices ranging from $53.75 to $63.68 per share. The derivative-security exercises were recorded at $0 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.